Clindamycin palmitate hydrochloride

Drug ingredient

CAS 25507-04-4

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 25507-04-4 — 1 HCl

US productionNot reported

Import value, 2024$546M

Top sourceItaly 41%

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 294190 · basket

These shares come from HS customs code 294190, which covers 90 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries

Country of origin for US imports, from Census customs data (2024).

IT 41%ItalyCN 24%ChinaDK 9%DenmarkHR 6%CroatiaIN 6%India

United Kingdom
Slovakia
Slovenia
Mexico
Canada
Germany
Belgium
Japan
Switzerland
Netherlands
Czech Republic
Uruguay
South Korea
Hong Kong
Portugal
Australia

12 FDA-registered drug labelers

Amneal Pharmaceuticals LLC

Amneal Pharmaceuticals of New York LLC

Aurobindo Pharma Limited

Bryant Ranch Prepack

Catalent Pharma Solutions, LLC

Chartwell RX, LLC

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

NorthStar Rx LLC

Pharmacia & Upjohn Company LLC

Rising Pharma Holdings, Inc.

Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

Zhejiang Tiantai Pharmaceutical Co., Ltd.

Why It Matters

Sectors

Health

Downstream Uses

Appears in 3 drug and cosmetic product listings (FDA).

•Clindamycin Palmitate Hydrochloride (Pediatric)
•Cleocin Pediatric
•Clindamycin Palmitate Hydrochloride

FDA Shortage Status

Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."

No Shortage

Shortage History

Rows group FDA shortage filings by drug product. Each manufacturer makes its own FDA shortage filing, so one product can carry several reports at once: Available, Limited Availability, Unavailable or to be discontinued.

to be discontinued
Clindamycin Palmitate Hydrochloride Injection
Shortage listed since February 27, 2026

See all current drug shortages

Chemical Identity

CAS25507-04-4

PubChem CID16052038

DTXSIDDTXSID3048734

FormulaC34H64Cl2N2O6S

Mol. Weight699.9 g/mol

SMILESCCCCCCCCCCCCCCCC(=O)OC1C(C(C(OC1SC)C(C(C)Cl)NC(=O)C2CC(CN2C)CCC)O)O.Cl

Data Sources

PubChem · compound 16052038Retrieved 2026-04-07
FDA National Drug Code directoryRetrieved 2026-04-25
FDA Drug ShortagesRetrieved 2026-10-04
US Census international tradeReporting year: 2024 · Retrieved 2026-10-04

← Back to Dashboard ← Back to Health

Brief citations

Clindamycin palmitate hydrochloride (CAS 25507-04-4) https://chemicalindependence.com/chemical/25507-04-4/ PubChem: 16052038. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/16052038 FDA National Drug Code directory: CAS 25507-04-4. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 25507-04-4. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 294190 for CAS 25507-04-4. Reporting year: 2024. https://usatrade.census.gov/